We systematically reviewed the literature on neuroimaging findings in Dravet syndrome (DS) and SCN1A-related epilepsies to classify the reported structural abnormalities observed on magnetic resonance imaging (MRI). We searched PubMed and MEDLINE from January 2000 to June 2024 for studies describing brain MRI findings in DS and SCN1A-related epilepsies through specific keywords and MeSH (Medical Subject Headings) terms. Duplicates were removed, and titles and abstracts were screened. Studies with absent/marginal MRI focus and reviews were excluded. Images available were evaluated by two pediatric neuroradiologists in consensus. Manual reference checks were performed. For the selection process, we followed the latest PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Nineteen studies met the inclusion criteria, all of which had an observational design, including case reports (n = 3), case series (n = 7), and larger cohorts (n = 9). The most observed brain MRI findings were cortical/parenchymal atrophy, hippocampal sclerosis (HS), and malformations of cortical development. Less frequent abnormalities include callosal dysgenesis and postseizure changes on diffusion-weighted imaging. There was variability in the description across studies, as expected. This review represents a valuable reference database for current and future genetic therapy trials. DS, particularly when associated with SCN1A variants, involves a variety of neuroimaging abnormalities, including HS, diffuse brain atrophy, and malformations of cortical development. The spectrum of these findings probably reflects the interplay between genetic susceptibility, seizure duration/severity, medication effects, and timing of imaging. To date, high-quality studies on brain MRI findings are limited, and future research, with more standardized methodologies, a longitudinal design, and larger sample sizes, are needed to further uncover these relationships and improve our understanding of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1111/epi.18344DOI Listing

Publication Analysis

Top Keywords

scn1a-related epilepsies
12
brain mri
12
mri findings
12
magnetic resonance
8
resonance imaging
8
findings scn1a-related
8
dravet syndrome
8
malformations cortical
8
cortical development
8
findings
6

Similar Publications

We systematically reviewed the literature on neuroimaging findings in Dravet syndrome (DS) and SCN1A-related epilepsies to classify the reported structural abnormalities observed on magnetic resonance imaging (MRI). We searched PubMed and MEDLINE from January 2000 to June 2024 for studies describing brain MRI findings in DS and SCN1A-related epilepsies through specific keywords and MeSH (Medical Subject Headings) terms. Duplicates were removed, and titles and abstracts were screened.

View Article and Find Full Text PDF

Dravet syndrome is a developmental and epileptic encephalopathy associated with pathogenic variants in SCN1A. Most disease-causing variants are located within coding regions, but recent work has shed light on the role of non-coding variants associated with a poison exon in intron 20 of SCN1A. Discovery of the SCN1A poison exon known as 20N has led to the first potential disease-modifying therapy for Dravet syndrome in the form of an antisense oligonucleotide.

View Article and Find Full Text PDF

variants cause a range of epilepsy syndromes, including Dravet syndrome, leading to early cognitive and functional impairment. Despite advances in medical management, drug-resistant epilepsy remains common. Vagal nerve stimulation (VNS) has been suggested reducing seizure frequency in these patients but there is a lack of long-term follow-up, quantitative analysis that corrected for confounding factors such as antiseizure medications (ASMs) and the impact of VNS settings on response.

View Article and Find Full Text PDF
Article Synopsis
  • EEG is crucial for diagnosing and managing genetic epilepsies in children, yet the relationship between quantitative EEG features and neurological outcomes is not well understood.* -
  • The study analyzed EEG data from children with specific genetic variants, used a control group, and created models to compare EEG features like the alpha-delta ratio to predict diagnoses and neurological outcomes.* -
  • Results showed significant differences in the alpha-delta ratio between genetic epilesies and controls, with high accuracy in predicting diagnoses, allowing for the identification of potential biomarkers for different genetic disorders in epilepsy.*
View Article and Find Full Text PDF
Article Synopsis
  • - This study focuses on understanding how disease characteristics and quality of life evolve across different life stages for individuals with Dravet syndrome and related seizure disorders, aiming to help doctors provide better personalized care.
  • - Researchers gathered data through questionnaires, medical records, and interviews, tracking changes in health-related quality of life over a seven-year period, with particular attention to how different factors impact patient well-being.
  • - Findings show that Dravet syndrome patients reported lower quality of life compared to those with non-Dravet conditions, although older Dravet patients exhibited improved quality of life, which was linked to fewer behavioral issues and better physical independence.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!